KR100250335B1 - A process for preparing 4-aminobenzamide derivatives - Google Patents

A process for preparing 4-aminobenzamide derivatives Download PDF

Info

Publication number
KR100250335B1
KR100250335B1 KR1019980010020A KR19980010020A KR100250335B1 KR 100250335 B1 KR100250335 B1 KR 100250335B1 KR 1019980010020 A KR1019980010020 A KR 1019980010020A KR 19980010020 A KR19980010020 A KR 19980010020A KR 100250335 B1 KR100250335 B1 KR 100250335B1
Authority
KR
South Korea
Prior art keywords
formula
group
acid
derivative represented
following formula
Prior art date
Application number
KR1019980010020A
Other languages
Korean (ko)
Other versions
KR19990075682A (en
Inventor
윤길중
오세한
최수진
문성철
Original Assignee
윤재승
주식회사대웅제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윤재승, 주식회사대웅제약 filed Critical 윤재승
Priority to KR1019980010020A priority Critical patent/KR100250335B1/en
Publication of KR19990075682A publication Critical patent/KR19990075682A/en
Application granted granted Critical
Publication of KR100250335B1 publication Critical patent/KR100250335B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE: Provided are 4-aminobenzamide derivatives, which have an effect on the activation of the stomach, and also can be used as an irritating agent for the stomach movement, a curing and analgesic agent for a gastric ulcer, a mental disorder, and a migraine. CONSTITUTION: The 4-aminobenzamide derivatives (formula 1) are produced by a process comprising the steps of: reacting a 4-amino benzoyl acid derivative and a phosphate compound in a solvent selected from the group consisting of dichloromethane, 1,2-dichloroethane, chloroform, or acetonitrile in the presence of a base to form a 4-phosphor amino benzoyl acid phosphate derivative (formula 4); reacting the 4-phosphor amino benzoyl acid phosphate derivative (formula 4) and an amine derivative (NHR2R3) to form a 4-phosphor amino benzamide derivative (formula 6); separating and recovering by adding an acid. In the formula, R1 is C1-C3 straight or branched alkoxy, R2 is hydrogen, or C1-C3 straight or branched alkyl, R3 is hydrogen, or -(CH2)n-Z, n is 0 or 1, Z is hydrogen, or di(C1-C3 alkyl)amino, R4 is hydrogen, or C1-C3 straight or branched alkyl, R5 is C1-C3 straight or branched alkyl, X is hydrogen, halogen, or nitro, and L is oxygen atom.

Description

4-아미노벤즈아미드 유도체의 제조방법Method for preparing 4-aminobenzamide derivative

본 발명은 4-아미노벤즈아미드 유도체의 제조방법에 관한 것으로서, 더욱 상세하게는 4-아미노벤조일산 유도체와 포스페이트 화합물을 반응시켜 신규 포스포아미노벤조일산 포스페이트를 중간체로 합성하고, 이를 아민 유도체와 반응시킴으로써 이량체 및 중합체 부산물의 생성을 최대한으로 억제하고 90% 이상의 높은 수율로 다음 화학식 1로 표시되는 4-아미노벤즈아미드 유도체를 제조하는 방법에 관한 것이다.The present invention relates to a method for producing 4-aminobenzamide derivatives, and more particularly, 4-aminobenzoyl acid derivatives are reacted with phosphate compounds to synthesize novel phosphoaminobenzoyl acid phosphates as intermediates, which are then reacted with amine derivatives. The present invention relates to a method for producing a 4-aminobenzamide derivative represented by the following Chemical Formula 1 by suppressing the production of dimers and polymer by-products to the maximum and having a high yield of 90% or more.

[화학식 1][Formula 1]

상기 화학식 1에서 :In Formula 1 above:

R1은 C1∼C3의 직쇄 또는 분쇄의 알콕시기를 나타내고;R 1 is an alkoxy group of a linear or branched C 1 ~C 3;

R2는 수소원자, 또는 C1∼C3의 직쇄 또는 분쇄의 알킬기를 나타내고;R 2 represents a hydrogen atom or a C 1 to C 3 straight or pulverized alkyl group;

R3은 수소원자, 또는 -(CH2)n-Z을 나타내고; n은 0 또는 1이고, 이때 Z은 수소원자, 디(C1∼C3의 알킬)아미노기, 또는를 나타내고; m는 0 또는 1이고, Q는 C1∼C3의 직쇄 또는 분쇄의 알콕시기이고, E는 수소원자, C1∼C3의 직쇄 또는 분쇄의 알킬옥시카보닐기, p-플루오로페녹시프로필기, 또는 벤질기를 나타내고;R 3 represents a hydrogen atom or-(CH 2 ) n -Z; n is 0 or 1, wherein Z is a hydrogen atom, a di (C 1 -C 3 alkyl) amino group, or Represents; and m is 0 or 1, Q is an alkoxy group of a linear or branched C 1 ~C 3, E is a phenoxy hydrogen atom, a straight-chain or alkyloxy carbonyl group, p- fluoro-milling of the C 1 ~C 3 Profile Group or benzyl group;

R4는 수소원자, 또는 C1∼ C3의 직쇄 또는 분쇄의 알킬기를 나타내고 ;R 4 represents a hydrogen atom or a C 1 to C 3 straight or pulverized alkyl group;

X는 수소원자, 할로겐원자 또는 니트로기를 나타낸다.X represents a hydrogen atom, a halogen atom or a nitro group.

상기 화학식 1로 표시되는 4-아미노벤즈아미드 유도체중의 대표적인 화합물로서 다음 화학식 10으로 표시되는 시사프라이드(cisapride)는 위장관 활성화에 특히 유효한 것으로 잘 알려져 있으며, 그 이외에도 N-피페리딘일 벤즈아미드 유도체는 위장계통운동의 자극제, 위궤양, 정신적 장애 및 편두통의 치료와 진통제로서 유용한 것으로 알려져 있다.As a representative compound of the 4-aminobenzamide derivative represented by Chemical Formula 1, cisapride represented by the following Chemical Formula 10 is well known to be particularly effective for gastrointestinal activation. In addition, N-piperidinyl benzamide derivatives It is known to be useful as a stimulant, gastric ulcer, mental disorders and migraines in gastrointestinal system exercise.

[화학식 10][Formula 10]

상기 화학식 1로 표시되는 일부 유도체의 제조방법은 몇몇 특허에 개시되어 있다.Methods of preparing some derivatives represented by Formula 1 have been disclosed in several patents.

예컨대 유럽공개특허 제76530호와 대한민국특허공고 제86-1584호에는 다음 반응식 1에 나타낸 바와 같이, 4-아미노벤조일산을 무수물 형태로 활성화하여 3-알콕시-4-피페리딘일아민 유도체와 반응시키는 제조방법이 기재되어 있다.For example, European Patent No.76530 and Korean Patent Publication No.86-1584 disclose the reaction of 3-aminobenzoyl acid in the form of anhydride to react with 3-alkoxy-4-piperidinylamine derivatives, as shown in Scheme 1 below. The preparation method is described.

상기 반응식 1에 따른 종래 아실화 방법에서는 10℃ 이하의 낮은 온도에서 카복실기를 무수물의 형태로 활성화시킨 후, 상온에서 18시간 동안 아실화 반응을 수행하고 있다. R이 에톡시카보닐기인 화합물의 경우는 수율이 80% 이었고, R이 p-플루오로페녹시프로필기인 화합물의 경우는 수율이 명시되어 있지 않았지만 본 발명자들이 동일한 방법으로 아실화 반응을 수행한 결과 수율이 20 ∼ 30%(HPLC 및 NMR 분석 결과)로 저조하였다.In the conventional acylation method according to Scheme 1, after activating the carboxyl group in the form of anhydride at a low temperature of 10 ° C or less, the acylation reaction is performed at room temperature for 18 hours. The yield was 80% for the compound in which R is an ethoxycarbonyl group, and the yield was not specified for the compound in which R is p-fluorophenoxypropyl group, but the inventors performed the acylation reaction in the same manner. Yield was low at 20-30% (HPLC and NMR analysis results).

상기 반응식 1에 따른 제조방법의 경우, 원료물질로 사용되는 4-아미노벤조일산의 구조적 특성으로 인하여 부산물의 생성은 거의 필연적이다. 즉, 아민기와 카복실기가 한 분자내에 존재함으로써 중합체 또는 이량체의 생성이 용이하고, 또한 아실화 반응 시간이 길어짐에 따라 활성화된 카복실기의 무수화물이 깨지는 등 기타 부반응이 생기는 문제점이 있다.In the case of the preparation method according to Scheme 1, the production of by-products is almost inevitable due to the structural characteristics of 4-aminobenzoyl acid used as a raw material. That is, since the amine group and the carboxyl group exist in one molecule, there is a problem in that the formation of the polymer or the dimer is easy, and as the acylation reaction time becomes longer, other side reactions occur such as the anhydride of the activated carboxyl group is broken.

또한, 본 발명의 발명자들은 상기 반응식 1에 따른 제조방법에서의 최적조건을 결정하기 위하여 반응시간을 길게하거나, 반응온도를 높이는 등 여러 가지의 반응 조건을 바꾸어 합성하여 보았지만 수율은 크게 향상되지 않았으며 부반응물은 여전히 생성되었다. 아실화 반응온도를 40℃ 이상 유지시키게 되면, 부반응으로 생기는 이량체의 생성율이 목적화합물에 대해서 17% 이상이 되는 것을 확인할 수 있었다[명세서내 비교예 참조].In addition, the inventors of the present invention synthesized various reaction conditions such as increasing the reaction time or increasing the reaction temperature in order to determine the optimum conditions in the preparation method according to Scheme 1, but the yield was not greatly improved. Side reactions were still produced. When the acylation reaction temperature was maintained at 40 ° C. or higher, it was confirmed that the formation rate of dimers generated by side reaction was 17% or more with respect to the target compound (see Comparative Example in the specification).

상기 화학식 1로 표시되는 일부 유도체의 제조를 위한 또다른 아실화 방법으로서는 4-아미노벤조일산을 원료물질로 하고 이를 1,3-디시클로헥실카보디이미드(DCC)와 같은 커플링 시약을 사용하여 제조하는 방법[스페인 특허 제2002640호], 또는 할로겐으로 활성화시켜 제조하는 방법[스페인 특허 제550123호] 등 통상의 아실화법이 공지되어 있다. 이 두 반응 역시 원료물질로 사용되는 4-아미노벤조일산의 구조적 특성으로 인해 발생될 수 있는 이량체 또는 중합체 생성을 근본적으로 방지할 수는 없다.As another acylation method for the preparation of some derivatives represented by the formula (1) using 4-aminobenzoyl acid as a raw material and using a coupling reagent such as 1,3-dicyclohexyl carbodiimide (DCC) Conventional acylation methods are known, such as the production method [Spanish Patent No. 2002640] or the method of making it activate by halogen (Spanish Patent No. 550123). These two reactions also do not fundamentally prevent the formation of dimers or polymers that may occur due to the structural properties of 4-aminobenzoyl acid used as raw material.

4-아미노벤조일산 유도체에서와 같이 아민기와 카복실기가 동시에 분자내 존재하는 화합물의 경우, 즉 펩타이드 또는 아미노벤조일산 유도체와 같은 구조는 상기한 선행기술들에서와 같이 중합체나 이량체와 같은 부반응이 생성되기 쉽고 반응 시간이 장시간 소요되는 문제가 지적되어 왔다. 이런 부반응을 방지하기 위하여 일반적으로 아민기에 보호기를 도입한 후에 카복실기 활성화 및 아실화 반응을 수행하고 있고, 필요에 따라 아민을 탈보호시키는 방법을 사용하고 있다. 그러나 이런 방법들은 아민보호기 도입과정 및 탈보호 과정이 추가되므로 반응이 복잡해지고 수율이 감소되는 문제점이 있다.In the case of compounds in which an amine group and a carboxyl group are present in the molecule at the same time as in a 4-aminobenzoyl acid derivative, ie, a structure such as a peptide or an aminobenzoyl acid derivative, a side reaction such as a polymer or a dimer is produced as in the above-mentioned prior arts. It has been pointed out that the problem is easy and takes a long time to react. In order to prevent such side reactions, generally, after introducing a protecting group into an amine group, a carboxyl group activation and acylation reaction are performed, and a method of deprotecting the amine as necessary is used. However, these methods have a problem in that the reaction is complicated and the yield is reduced since the introduction of the amine protecting group and the deprotection process are added.

따라서, 4-아미노벤조일산을 활성화시키면서도 분자간의 중합 반응을 최소화 할 수 있는 새로운 방법의 개발이 절실히 요구된다.Therefore, there is an urgent need for the development of new methods that can minimize intermolecular polymerization while activating 4-aminobenzoyl acid.

본 발명자들은 4-아미노벤조일산 유도체의 아실화 반응에서의 부반응을 최대한 억제하고, 아민보호기 도입반응 및 탈보호 반응이 용이하면서도 카복실기의 활성화를 동시에 수행할 수 있는 물질을 찾고자 노력하였고, 그 결과 포스페이트계열의 화합물이 매우 적합하다는 사실을 알게되었다.The present inventors have tried to find a substance that can inhibit side reactions in the acylation reaction of 4-aminobenzoyl acid derivatives as much as possible, and is capable of simultaneously activating carboxyl groups while facilitating amine protecting group introduction and deprotection reactions. It has been found that phosphate-based compounds are very suitable.

따라서, 본 발명은 4-아미노벤조일산 유도체에 아민기 보호기능과 카복실기의 활성화기능을 동시에 수행할 수 있는 포스페이트 계열의 화합물을 도입하여 4-포스포아미노벤조일산 포스페이트를 합성하였고, 이러한 신규 중간체를 여러 아민류와 반응시켜 목적으로 하는 상기 화학식 1로 표시되는 화합물을 빠른 반응시간내에 고수율로 제조함으로써 본 발명을 완성하였다.Therefore, the present invention synthesized 4-phosphoaminobenzoyl acid phosphate by introducing a phosphate-based compound capable of simultaneously performing amine group protection function and carboxyl group activation function to 4-aminobenzoyl acid derivative. The present invention was completed by preparing a compound represented by Chemical Formula 1 to a high yield within a quick reaction time by reacting with various amines.

즉, 본 발명은 아민기와 카복실기를 한 분자내에 포함하고 있는 4-아미노벤조일산 유도체의 아실화 반응에서 부반응물의 생성을 최대로 억제하고 있다는 점에서 다른 선행기술과 차별화된다.In other words, the present invention is distinguished from other prior arts in that the acylation reaction of the 4-aminobenzoyl acid derivative including the amine group and the carboxyl group in one molecule is suppressed to the maximum.

따라서, 본 발명은 의약 물질로서 유용한 4-아미노벤즈아미드류 및 여러 가지 펩타이드 구조를 가진 화합물의 산업적 생산이 가능한 신규 제조방법을 제공하는데 그 목적이 있다.Accordingly, an object of the present invention is to provide a novel preparation method capable of industrial production of 4-aminobenzamides and compounds having various peptide structures useful as medicinal substances.

본 발명은 다음 화학식 2로 표시되는 4-아미노벤조일산 유도체를 염기 존재하에 디클로로메탄, 1,2-디클로로에탄, 클로로포름 또는 아세토니트릴 중에서 선택한 용매 주에서 다음 화학식 3으로 표시되는 포스페이트 화합물과 반응시켜 카복실기의 활성화 및 아민보호기를 동시에 가지는 다음 화학식 4로 표시되는 4-포스포아미노벤조 일산 포스페이트 유도체를 제조하고; 화학식 4로 표시되는 4-포스포아미노벤조일산 포스페이트 유도체와 다음 화학식 5로 표시되는 아민 유도체를 반응시켜 다음 화학식 6으로 표시되는 4-포스포아미노벤즈아미드 유도체를 제조한 후, 반응용액에 산(acid)을 첨가한 다음 통상의 분리과정을 통하여 다음 화학식 1로 표시되는 4-아미노 벤즈아미드 유도체를 제조하는 방법에 그 특징이 있다.The present invention is reacted with a carboxyl compound by reacting a 4-aminobenzoylic acid derivative represented by the following formula (2) with a phosphate compound represented by the following formula (3) in a solvent selected from dichloromethane, 1,2-dichloroethane, chloroform or acetonitrile in the presence of a base. Preparing a 4-phosphoaminobenzoic acid phosphate derivative represented by the following formula (4) having an activation of a group and an amine protecting group simultaneously; By reacting the 4-phosphoaminobenzoyl acid phosphate derivative represented by the formula (4) with the amine derivative represented by the following formula (5) to prepare a 4-phosphoaminobenzamide derivative represented by the following formula (6), and then added an acid ( acid) is added and then a conventional separation process is characterized by a method for producing the 4-amino benzamide derivative represented by the following formula (1).

[화학식 2][Formula 2]

[화학식 3][Formula 3]

[화학식 4][Formula 4]

[화학식 5][Formula 5]

[화학식 6][Formula 6]

[화학식 1][Formula 1]

상기 화학식에서 ; R1은 C1∼C3의 직쇄 또는 분쇄의 알콕시기를 나타내고;In the above formula; R 1 is an alkoxy group of a linear or branched C 1 ~C 3;

R2는 수소원자, 또는 C1∼C3의 직쇄 또는 분쇄의 알킬기를 나타내고;R 2 represents a hydrogen atom or a C 1 to C 3 straight or pulverized alkyl group;

R3은 수소원자, 또는 ;-(CH2)n-Z을 나타내고; n은 0 또는 1이고, 이때 Z은 수소원자, 디(C1∼C3의 알킬)아미노기, 또는를 나타내고; m는 0 또는 1이고, Q는 C1∼C3의 직쇄 또는 분쇄의 알콕시기이고, E는 수소원자, C1∼C3의 직쇄 또는 분쇄의 알킬옥시카보닐기, p-플루오로페녹시프로필기, 또는 벤질기를 나타내고;R 3 represents a hydrogen atom or ;-( CH 2 ) n -Z; n is 0 or 1, wherein Z is a hydrogen atom, a di (C 1 -C 3 alkyl) amino group, or Represents; and m is 0 or 1, Q is an alkoxy group of a linear or branched C 1 ~C 3, E is a phenoxy hydrogen atom, a straight-chain or alkyloxy carbonyl group, p- fluoro-milling of the C 1 ~C 3 Profile Group or benzyl group;

R4는 수소원자, 또는 C1∼C3의 직쇄 또는 분쇄의 알킬기를 나타내고;R 4 represents a hydrogen atom or a C 1 to C 3 straight or pulverized alkyl group;

R5는 C1∼C3의 직쇄 또는 분쇄의 알킬기이며 ;R 5 is a C 1 -C 3 linear or pulverized alkyl group;

X는 수소원자, 할로겐원자 또는 니트로기를 나타내고;X represents a hydrogen atom, a halogen atom or a nitro group;

Y는 할로겐원자를 나타내고;Y represents a halogen atom;

L은 산소원자를 나타낸다.L represents an oxygen atom.

이와같은 본 발명을 더욱 상세히 설명하면 다음과 같다.Referring to the present invention in more detail as follows.

본 발명은 아민기와 카복실기를 하나의 분자내에 포함하고 있는 4-아미노벤조일산 유도체의 카복실기를 활성화시켜 아실화 반응을 수행함에 있어 발생될 수 있는 중합체 및 이량체 등의 부반응물의 생성을 최소화시키기 위한 제조방법으로서, 아민기 보호능과 카복실기 활성화능을 동시에 갖는 신규한 중간체를 제조함으로써 다단계 제조공정을 거쳐야 하는 번거러움을 극복하고, 목적된 4-아미노벤즈아미드 유도체를 고수율로 제조하는 방법에 관한 것이다.The present invention is to minimize the production of side reactions such as polymers and dimers that can be generated in the acylation reaction by activating the carboxyl group of the 4-aminobenzoyl acid derivative containing the amine group and the carboxyl group in one molecule As a preparation method, a novel intermediate having both an amine group protecting ability and a carboxyl group activating ability is produced to overcome the inconvenience of having to go through a multi-step manufacturing process and to prepare a desired 4-aminobenzamide derivative in high yield. will be.

본 발명의 명세서 전반에 걸쳐, 그 자체로 또는 각종기에 포함되어 사용된 용어 “할로겐원자”는 예를들면 불소(F), 염소(Cl), 브롬(Br), 요오드(I) 등을 포함한다. 그 자체로 또는 각종기에 포함되어 사용된 “C1∼C3의 직쇄 또는 분쇄의 알킬기”는 예를들면 메틸기, 에틸기, 프로필기, 이소프로필기 등을 포함한다. 그 자체로 또는 각종기에 포함되어 사용된 용어 “C1∼C3의 직쇄 또는 분쇄의 알콕시기”는 예를들면 메톡시기, 에톡시기, 프로폭시기, 이소프로폭시기 등을 포함한다.Throughout the specification of the present invention, the term “halogen atom” used by itself or in various groups includes, for example, fluorine (F), chlorine (Cl), bromine (Br), iodine (I), and the like. . The "C 1 -C 3 linear or pulverized alkyl group" used by itself or in various groups includes, for example, methyl group, ethyl group, propyl group, isopropyl group and the like. The term “C 1 to C 3 straight chain or pulverized alkoxy group” used by itself or in various groups includes, for example, methoxy group, ethoxy group, propoxy group, isopropoxy group and the like.

본 발명에 따른 상기 화학식 1로 표시되는 4-아미노벤즈아미드 유도체의 제조과정을 간략히 나타내면 다음 반응식 2와 같다.The preparation process of the 4-aminobenzamide derivative represented by Chemical Formula 1 according to the present invention is briefly shown in Scheme 2 below.

상기 반응식 2에서 : R1, R2, R3, R4, R5, X, Y 및 L은 각각 상기에서 정의한 바와 같다.In Scheme 2: R 1 , R 2 , R 3 , R 4 , R 5 , X, Y and L are as defined above, respectively.

본 발명은 상기 반응식 2에 나타낸 바와 같이 카복실기 활성화 및 아민보호기의 도입을 동시에 수행하여 신규한 화합물인 화학식 4로 표시되는 4-포스포아미노벤조일산 포스페이트 화합물을 중간체로 제조한데 가장 큰 특징이 있다.The present invention has the greatest feature in preparing the 4-phosphoaminobenzoyl acid phosphate compound represented by Chemical Formula 4, which is a novel compound, as an intermediate by simultaneously activating a carboxyl group and introducing an amine protecting group as shown in Scheme 2. .

본 발명의 화학식 4로 표시되는 신규 중간체는 활성화된 구조임에도 불구하고 화학식 5로 표시되는 아민 유도체와 반응시에 이량체 또는 중합체가 거의 생성되지 않는다. 그 이유는 카복실기와 아민기에 포스페이트 반응을 시킬때, 반응성의 차이로 인하여 카복실기 보다는 아민기에 포스페이트 결합이 먼저 생성되어, 이량체의 생성을 근본적으로 방지하기 때문이다. 화학식 2로 표시되는 4-아미노벤조일산 유도체에 화학식 3으로 표시되는 포스페이트 화합물을 반응시키면 선택적으로 아민기에 먼저 포스페이트 보호기가 붙는다는 사실에 대해서는 다음의 참조 예에서15N-NMR 및31P-NMR 분석을 통하여 규명하였다.Although the novel intermediate represented by the general formula (4) of the present invention has an activated structure, almost no dimer or polymer is produced upon reaction with the amine derivative represented by the general formula (5). The reason for this is that when phosphate reacts with the carboxyl group and the amine group, phosphate bonds are first formed in the amine group rather than the carboxyl group due to the difference in reactivity, thereby fundamentally preventing the formation of dimers. Regarding the fact that reacting the 4-aminobenzoyl acid derivative represented by the formula (2) with the phosphate compound represented by the formula (3) selectively attaches the phosphate protecting group to the amine group first, the 15 N-NMR and 31 P-NMR analyzes in the following reference examples It was identified through.

또한, 본 발명에서 아민 보호기와 카복실기 활성화를 위해 사용되는 화학식 3으로 표시되는 포스페이트 화합물은 통상적인 포스페이트 화합물이다. 예를들면, 디메틸클로로포스페이트, 디에틸클로로포스페이트, 디에틸클로로치오포스페이트, 디페닐클로로포스페이트, 비스(2,4-디클로로페닐)클로로포스페이트, 비스(3,5-디메틸페닐)클로로포스페이트, 비스(2-메틸페닐)클로로포스페이트, 디에틸브로모포스페이트, 디이소프로필플루오로포스페이트, 디에틸시아노포스페이트, 비스(2,2,2-트리클로로)포스포라이드 등이다. 특히 바람직하기로는 디메틸클로로포스페이트, 디에틸클로로포스페이트, 디에틸브로모포스페이트 등이다.In addition, in the present invention, the phosphate compound represented by Formula 3 used for amine protecting group and carboxyl group activation is a conventional phosphate compound. For example, dimethylchlorophosphate, diethylchlorophosphate, diethylchlorothiophosphate, diphenylchlorophosphate, bis (2,4-dichlorophenyl) chlorophosphate, bis (3,5-dimethylphenyl) chlorophosphate, bis ( 2-methylphenyl) chlorophosphate, diethylbromophosphate, diisopropylfluorophosphate, diethylcyanophosphate, bis (2,2,2-trichloro) phosphoride and the like. Especially preferred are dimethylchlorophosphate, diethylchlorophosphate, diethylbromophosphate and the like.

상기 화학식 2로 표시되는 4-아미노벤조일산 유도체와 화학식 3으로 표시되는 포스페이트 화합물의 반응에서는 염기를 사용하는 것이 바람직하며, 이때 사용될 수 있는 염기는 특별히 제한되어 있지 않고, 광범위하게 적절히 결정된다. 염기는 일반적으로 사용되는 아민류나 금속을 포함하는 유기계 및 무기계 염기를 모두 사용할 수 있으며, 2종 이상의 염기를 혼합하여 쓸 수도 있다. 화학식 3으로 표시되는 포스페이트 화합물은 화학식 2로 표시되는 4-아미노벤조일산 유도체에 대하여 몰비로 최소한 약 2몰 이상, 바람직하게는 약 2몰 ∼ 3몰비의 양으로 사용한다.In the reaction of the 4-aminobenzoyl acid derivative represented by the formula (2) with the phosphate compound represented by the formula (3), it is preferable to use a base, and the base that can be used is not particularly limited, and a wide range is appropriately determined. As a base, both the organic and inorganic bases containing amines and metals generally used can be used, and 2 or more types of bases can also be mixed and used. The phosphate compound represented by the general formula (3) is used in an amount of at least about 2 moles or more, preferably about 2 to 3 molar ratios in molar ratio with respect to the 4-aminobenzoyl acid derivative represented by the general formula (2).

또한, 반응용매는 통상적으로 사용되고 있는 불활성 용매이며, 특히 비양자성 극성 용매(aprotic polar solvent)를 사용하는 것이 바람직하다. 예를들면, 디클로로메탄, 1,2-디클로로에탄, 클로로포름, 아세토니트릴, 디메틸포름아미드, 디메틸아세트아미드, 헥사메틸포스포아미드 등이며, 그 중에서도 비점이 낮은 용매인 디클로로메탄, 1,2-디클로로에탄, 클로로포름 또는 아세토니트릴 등을 사용하는 것이 바람직하다.In addition, the reaction solvent is an inert solvent which is commonly used, and it is particularly preferable to use an aprotic polar solvent. For example, dichloromethane, 1,2-dichloroethane, chloroform, acetonitrile, dimethylformamide, dimethylacetamide, hexamethylphosphoamide, etc. Among them, dichloromethane and 1,2-dichloro which are low boiling point solvents Preference is given to using ethane, chloroform or acetonitrile or the like.

상기와 같은 조작을 통하여 아민기의 보호와 카복실기의 활성화 작용을 동시에 갖는 화학식 4로 표시되는 신규한 중간체를 제조함으로써, 다음에서 수행하게 되는 아실화 반응을 고수율로 수행할 수 있게 된다.By preparing a novel intermediate represented by the formula (4) having both the protection of the amine group and the activating action of the carboxyl group through the above operation, it is possible to perform the acylation reaction to be carried out in a high yield.

또한, 화학식 4로 표시되는 중간체 화합물은 반응물로부터 분리하여 화학식 5로 표시되는 아민유도체와 반응시킬 수도 있고, 또는 분리하지 않고 곧바로 아민 유도체와 반응시켜 아실화 반응을 수행할 수도 있다.In addition, the intermediate compound represented by the formula (4) may be separated from the reactant and reacted with the amine derivative represented by the formula (5), or may be directly reacted with the amine derivative without separation to perform an acylation reaction.

본 발명에 따른 아실화 반응은 기존 선행기술에 제시한 아실화 반응에 비하여 특히 반응 속도가 빠르며, 반응도 거의 정량적으로 수행된다.The acylation reaction according to the present invention is particularly faster than the acylation reaction described in the prior art, and the reaction is also carried out almost quantitatively.

본 발명에 따른 아실화 반응으로부터 생긴 중간체 화합물인 상기 화학식 6으로 표시되는 4-포스포아미노벤즈아미드 유도체 역시 신규 화합물이다. 또한, 화학식 6으로 표시되는 중간체 화합물은 유기용매를 이용한 간단한 추출에 의하여 반응물로부터 용이하게 분리할 수도 있고, 또는 반응용액으로부터 분리하지 않고 직접 산(acid)을 가하여 탈보호(deprotection)시켜 본 발명이 목적으로 하는 화학식 1로 표시되는 아미노벤즈아미드 유도체를 수득할 수도 있다.The 4-phosphoaminobenzamide derivative represented by the above formula (6), which is an intermediate compound resulting from the acylation reaction according to the present invention, is also a novel compound. In addition, the intermediate compound represented by Chemical Formula 6 may be easily separated from the reactants by simple extraction using an organic solvent, or may be deprotected by adding acid directly without separating from the reaction solution. A desired aminobenzamide derivative represented by the formula (1) can also be obtained.

본 발명에 따른 탈보호 반응은 별도의 추가공정으로 수행되는 것이 아니라 반응물로부터 목적물을 분리 회수하는 과정(work up)에서 산(acid)을 투입하므로써 수행된다. 이때 사용되는 산은 일반적으로 통용되는 산을 사용할 수 있다. 예를들면 염산, 황산, 질산, 인산 및 과염소산을 포함하는 무기산; 포름산, 아세트 산 및 프로피온산과 같은 저급알칸산; 벤조산, 메탄설폰산, 에탄설폰산, 벤젠설폰산 및 4-메틸-벤젠설폰산을 포함하는 유기산 등이며, 바람직하기로는 염산과 황산 등의 강산류를 사용하는 것이다.The deprotection reaction according to the invention is not carried out in a separate additional process but by the addition of acid in the work up to separate the desired product from the reactants. The acid used at this time can use the acid generally used. Inorganic acids including, for example, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and perchloric acid; Lower alkanoic acids such as formic acid, acetic acid and propionic acid; Organic acids, including benzoic acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, and 4-methyl- benzenesulfonic acid, etc., Preferably, strong acids, such as hydrochloric acid and a sulfuric acid, are used.

이상에서는 상기 반응식 2에 나타낸 바와 같이, 본 발명에서 생성될 수 있는 중간체를 포함하여 3단계 제조과정으로 설명하였지만, 실제 합성시에는 중간체로서 생성되는 화학식 4 및 화학식 6으로 표시되는 화합물의 분리 과정없이 일용기 반응(one-pot reaction)으로 수행할 수도 있다.In the above, as shown in Scheme 2, it was described as a three-step manufacturing process including the intermediate that can be produced in the present invention, in the actual synthesis without the separation process of the compound represented by Formula 4 and Formula 6 generated as an intermediate It may also be carried out by a one-pot reaction.

이상에서 설명한 바와 같이 본 발명에 따른 제조방법은 90% 이상의 고수율로 목적화합물을 제조할 수 있으며, 중합체 및 이량체 생성 등의 부반응을 방지할 수 있으며, 공정이 산업적 적용에 매우 용이한 우수성을 가진다.As described above, the production method according to the present invention can prepare the target compound in a high yield of 90% or more, can prevent side reactions such as the formation of polymers and dimers, and the process is very easy for industrial application. Have

이와 같은 본 발명을 더욱 상세히 설명하면 다음과 같은 바, 본 발명이 이에 의하여 한정되는 것은 아니다.When the present invention is described in more detail as follows, the present invention is not limited thereto.

[참조예][Reference Example]

[5-클로로-2-메톡시-4-(디에톡시포스포닐아미노)-벤조일산의 제조][Preparation of 5-chloro-2-methoxy-4- (diethoxyphosphonylamino) -benzoic acid]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(1g, 10mmol), 탄산칼륨(1.4g, 10mmol)을 가하고, 천천히 디에틸클로로포스페이트(0.8㎖, 5.5mmol)를 가한 후 6시간 동안 교반시켰다. 이 반응 혼합물을 간단히 여과한 후 여액을 감압 농축하고, 이때 얻어진 오일상의 물질을 진공 건조하여 NMR 분석을 하였다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (1 g, 10 mmol) and potassium carbonate (1.4 g, 10 mmol) were added to dichloromethane (30 mL), and slowly Diethylchlorophosphate (0.8 mL, 5.5 mmol) was added and stirred for 6 hours. The reaction mixture was briefly filtered and the filtrate was concentrated under reduced pressure, and the oily substance thus obtained was vacuum dried and subjected to NMR analysis.

1H-NMR(CDCl3, ppm) : δ 1.17(6H, t), 3.60(3H, s), 4.08(4H, m), 6.43(1H, s), 7.51(1H, s) 1 H-NMR (CDCl 3 , ppm): δ 1.17 (6H, t), 3.60 (3H, s), 4.08 (4H, m), 6.43 (1H, s), 7.51 (1H, s)

15N-NMR(CDCl3, ppm) : δ 91.40 15 N-NMR (CDCl 3 , ppm): δ 91.40

31P-NMR(CDCl3, ppm) : δ -11.89 31 P-NMR (CDCl 3 , ppm): δ -11.89

[실시예 1]Example 1

[5-클로로-2-메톡시-4-(디에톡시포스포닐아미노)-벤조일디에톡시포스페이트의 제조][Preparation of 5-chloro-2-methoxy-4- (diethoxyphosphonylamino) -benzoyldiethoxyphosphate]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응 혼합물을 간단히 여과한 후 여액을 감압 농축하고, 진공 건조하여 목적화합물 2.32g(수율 98%)을 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethyl chlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. The reaction mixture was briefly filtered and the filtrate was concentrated under reduced pressure and dried under vacuum to yield 2.32 g (yield 98%) of the title compound.

1H-NMR(CDCl3, ppm) : δ 1.30(12H, txt), 3.80(3H, s), 4.17(8H, m), 6.38(1H, s), 7.66(1H, s) 1 H-NMR (CDCl 3 , ppm): δ 1.30 (12H, txt), 3.80 (3H, s), 4.17 (8H, m), 6.38 (1H, s), 7.66 (1H, s)

13C-NMR(CDCl3, ppm) : δ 16.42, 56.30, 65.37, 65.59, 97.98, 109.99, 134.46, 151.34, 158.25, 162,39 13 C-NMR (CDCl 3 , ppm): δ 16.42, 56.30, 65.37, 65.59, 97.98, 109.99, 134.46, 151.34, 158.25, 162,39

15N-NMR(CDCl3, ppm) : δ 91.40 15 N-NMR (CDCl 3 , ppm): δ 91.40

31P-NMR(CDCl3, ppm) : δ -11.89, 1.53 31 P-NMR (CDCl 3 , ppm): δ -11.89, 1.53

[실시예 2]Example 2

[5-클로로-2-메톡시-4-(디에톡시포스포닐아미노)-벤조일디에톡시포스페이트의 제조][Preparation of 5-chloro-2-methoxy-4- (diethoxyphosphonylamino) -benzoyldiethoxyphosphate]

디에틸브로모포스페이트(2.4g, 11mmol)를 사용하여 상기 실시예 1과 동일한 방법으로 하여 목적화합물 2.32g(수율 98%)를 얻었다.2.32 g (yield 98%) of the title compound was obtained in the same manner as in Example 1 using diethylbromophosphate (2.4 g, 11 mmol).

[실시예 3]Example 3

[5-클로로-2-메톡시-4-(디메톡시포스포닐아미노)-벤조일디메톡시포스페이트의 제조][Preparation of 5-chloro-2-methoxy-4- (dimethoxyphosphonylamino) -benzoyldimethoxyphosphate]

디메틸클로로포스페이트(1.2 ㎖, 11mmol)를 사용하여 상기 실시예 1과 동일한 방법으로 하여 목적화합물 2.0g(수율 98%)을 얻었다.2.0 g (yield 98%) of the title compound was obtained in the same manner as in Example 1 using dimethylchlorophosphate (1.2 ml, 11 mmol).

1H-NMR(CDCl3, ppm) : δ 3.82(3H, s), 4.01(12H, m), 6.35(1H, s), 7.68(1H, s) 1 H-NMR (CDCl 3 , ppm): δ 3.82 (3H, s), 4.01 (12H, m), 6.35 (1H, s), 7.68 (1H, s)

[실시예 4]Example 4

[시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-이소프로폭시-4-피페리딘일]-2-메톡시벤즈아미드의 제조][Cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-isopropoxy-4-piperidinyl] -2-methoxybenzamide Produce]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응액에 시스-1-[3-(4-플루오로페녹시)프로필]-4-아미노-3-이소프로폭시피페리딘 (1.55g, 5mmol)을 가하고, 2시간 동안 교반시켰다. 이 반응액을 여과하여, 용매를 감압농축 시킨 후 잔사에 진한 염산(30㎖)을 넣고 60℃에서 1시간 정도 교반한 다음 수산화나트륨 용액으로 중성화하였다. 디클로로메탄(30㎖×3)으로 추출하고, 무수 황산나트륨으로 수분을 제거한 후 여과하였다. 이 여액을 감압 농축하고, 건조한 유상 잔류물을 2-프로판올 중에서 결정화하여 목적화합물 2.22g (수율 90%)을 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethylchlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. Cis-1- [3- (4-fluorophenoxy) propyl] -4-amino-3-isopropoxypiperidine (1.55 g, 5 mmol) was added to the reaction solution, and the mixture was stirred for 2 hours. The reaction solution was filtered, the solvent was concentrated under reduced pressure, and concentrated hydrochloric acid (30 ml) was added to the residue, followed by stirring at 60 ° C for about 1 hour, followed by neutralization with sodium hydroxide solution. The mixture was extracted with dichloromethane (30 mL × 3), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the dried oily residue was crystallized in 2-propanol to give 2.22 g (yield 90%) of the title compound.

1H-NMR(CDCl3, ppm) : δ 1.15(6H, s), 1.21(2H, m), 1.91(2H, m), 2.17(2H,m), 2.58(2H, m), 2.91(1H, m), 3,05(1H, m), 3.44(1H, s), 3.71(1H,m) 3.90(3H, s), 3.94(2H, t), 4.21(1H, m), 4.41(2H, s), 6.31(1H, s), 6.82(2H, m), 6.98(2H, m), 8.13(1H, s), 8.21(1H, d) 1 H-NMR (CDCl 3 , ppm): δ 1.15 (6H, s), 1.21 (2H, m), 1.91 (2H, m), 2.17 (2H, m), 2.58 (2H, m), 2.91 (1H , m), 3,05 (1H, m), 3.44 (1H, s), 3.71 (1H, m) 3.90 (3H, s), 3.94 (2H, t), 4.21 (1H, m), 4.41 (2H , s), 6.31 (1H, s), 6.82 (2H, m), 6.98 (2H, m), 8.13 (1H, s), 8.21 (1H, d)

[실시예 5]Example 5

[시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조]Preparation of [cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-methoxy-4-piperidinyl] -2-methoxybenzamide ]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응 혼합물을 여과한 여액에 시스-1-[3-(4-플루오로페녹시)프로필]-4-아미노-3-메톡시피페리딘(1.4g, 5mmol)을 가하고, 2시간 동안 교반시켰다. 용매를 감압농축 시킨 후, 잔사에 진한 염산(30㎖)을 넣고 60℃에서 1시간 정도 교반한 다음 수산화나트륨 용액으로 중성화 하였다. 디클로로메탄(30㎖× 3)으로 추출하고, 무수 황산나트륨으로 수분을 제거한 후 여과하였다. 이 여액을 감압농축하고, 건조한 유상 잔류물을 2-프로판올 중에서 결정화하여 목적화합물 2.21g(수율 95%)을 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethyl chlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. Cis-1- [3- (4-fluorophenoxy) propyl] -4-amino-3-methoxypiperidine (1.4 g, 5 mmol) was added to the filtrate, and the reaction mixture was stirred for 2 hours. . The solvent was concentrated under reduced pressure, and concentrated hydrochloric acid (30 ml) was added to the residue, followed by stirring at 60 ° C. for about 1 hour, followed by neutralization with sodium hydroxide solution. Extract with dichloromethane (30 mL × 3), remove water with anhydrous sodium sulfate, and filter. The filtrate was concentrated under reduced pressure, and the dried oily residue was crystallized in 2-propanol to give 2.21 g (yield 95%) of the title compound.

m,p. : 120 ∼ 130℃m, p. : 120-130 degreeC

1H-NMR(CDCl3, ppm) : δ 1.20(2H, m), 1.86(2H, m), 2.19(2H, m), 2.56(2H, m), 2.88(1H, m), 3.08(1H, m), 3.44(4H, s), 3.89(3H, s), 3.96(2H, t), 4.19(1H, m), 4.42(2H, s), 6.30(1H, s), 6.84(2H, m), 6.96(2H, m), 8.11(1H, s), 8.24(1H, d) 1 H-NMR (CDCl 3 , ppm): δ 1.20 (2H, m), 1.86 (2H, m), 2.19 (2H, m), 2.56 (2H, m), 2.88 (1H, m), 3.08 (1H) , m), 3.44 (4H, s), 3.89 (3H, s), 3.96 (2H, t), 4.19 (1H, m), 4.42 (2H, s), 6.30 (1H, s), 6.84 (2H, m), 6.96 (2H, m), 8.11 (1H, s), 8.24 (1H, d)

13C-NMR(CDCl3, ppm) : δ 26.81, 27.80, 48.08, 51.90, 53.55, 55.13, 55.91, 56.96, 66.88, 97.84, 111.46, 112.60, 115.32, 115,43, 115.54, 115.84, 132.93, 146.58, 155.00, 155.52, 157,52, 158.68, 163.70 13 C-NMR (CDCl 3 , ppm): δ 26.81, 27.80, 48.08, 51.90, 53.55, 55.13, 55.91, 56.96, 66.88, 97.84, 111.46, 112.60, 115.32, 115,43, 115.54, 115.84, 132.93, 146.58, 155.00, 155.52, 157,52, 158.68, 163.70

[실시예 6]Example 6

[시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조]Preparation of [cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-methoxy-4-piperidinyl] -2-methoxybenzamide ]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 액에 시스-1-[3-(4-플루오로페녹시)프로필]-4-아미노-3-메톡시 피페리딘 (1.4g, 5mmol)을 가하고, 2시간 동안 교반시킨 후 여과하여 상기 실시예 5와 같은 조작을 통하여 목적화합물 2.20g(수율 95%)을 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethyl chlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. Cis-1- [3- (4-fluorophenoxy) propyl] -4-amino-3-methoxy piperidine (1.4 g, 5 mmol) was added to this solution, which was stirred for 2 hours and filtered. 2.20 g (yield 95%) of the title compound was obtained through the same operation as in Example 5.

[실시예 7]Example 7

[시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조]Preparation of [cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-methoxy-4-piperidinyl] -2-methoxybenzamide ]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 브로모포스페이트(2.4g, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응 혼합물을 여과한 여액에 시스-1-[3-(4-플루오로페녹시)프로필]-4-아미노-3-메톡시피페리딘(1.4g, 5mmol)을 가하고, 2시간 동안 교반시킨 후 상기 실시예 5와 같은 조작을 통하여 목적화합물 2.26g(수율 97%)을 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethyl bromophosphate (2.4 g, 11 mmol) was added and stirred for 4 hours. Cis-1- [3- (4-fluorophenoxy) propyl] -4-amino-3-methoxypiperidine (1.4 g, 5 mmol) was added to the filtrate of the reaction mixture, which was stirred for 2 hours. Thereafter, 2.26 g (yield 97%) of the title compound was obtained through the same operation as in Example 5.

[실시예 8]Example 8

[시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조]Preparation of [cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-methoxy-4-piperidinyl] -2-methoxybenzamide ]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디메틸 클로로포스페이트(1.2㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응 혼합물을 여과한 여액에 시스-1-[3-(4-플루오로페녹시)프로필]-4-아미노-3-메톡시피페리딘(1.4g, 5mmol)을 가하고, 2시간 동안 교반시킨 후 상기 실시예 5와 같은 방법으로 하여 목적화합물 2.14g(수율 92%)를 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Dimethyl chlorophosphate (1.2 ml, 11 mmol) was added and stirred for 4 hours. Cis-1- [3- (4-fluorophenoxy) propyl] -4-amino-3-methoxypiperidine (1.4 g, 5 mmol) was added to the filtrate of the reaction mixture, which was stirred for 2 hours. Thereafter, 2.14 g (yield 92%) of the title compound was obtained in the same manner as in Example 5.

[실시예 9]Example 9

[4-아미노-5-클로로-N-[1-벤질-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조][Preparation of 4-amino-5-chloro-N- [1-benzyl-3-methoxy-4-piperidinyl] -2-methoxybenzamide]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응액에 1-벤질-3-메톡시-4-피페리딘일아민(1.1g, 5mmol)을 가하고, 상기 실시예 5와 같은 방법으로 하여 목적화합물 2.0g(수율 98%)를 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethyl chlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. 1-benzyl-3-methoxy-4-piperidinylamine (1.1 g, 5 mmol) was added to the reaction solution, and 2.0 g (yield 98%) of the target compound was obtained in the same manner as in Example 5.

m.p. : 180 ∼ 190℃m.p. : 180 to 190 ° C

1H-NMR(CDCl3, ppm) : δ 1.81(2H, m), 2.02(1H, m), 2.17(2H, m), 2.61(2H, m), 2.77(1H, m), 3.17(1H, m), 3.46(3H, s), 3.91(3H, s), 4.15(1H, m), 4.46(2H, s), 6.28(1H, s), 7.35(5H, m), 8.10(1H, s), 8.22(1H, d) 1 H-NMR (CDCl 3 , ppm): δ 1.81 (2H, m), 2.02 (1H, m), 2.17 (2H, m), 2.61 (2H, m), 2.77 (1H, m), 3.17 (1H) , m), 3.46 (3H, s), 3.91 (3H, s), 4.15 (1H, m), 4.46 (2H, s), 6.28 (1H, s), 7.35 (5H, m), 8.10 (1H, s), 8.22 (1 H, d)

[실시예 10]Example 10

[4-디에틸포스포아미노-5-클로로-N-메틸-2-메톡시벤즈아미드의 제조][Production of 4-diethylphosphoamino-5-chloro-N-methyl-2-methoxybenzamide]

아세토니트릴(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응 혼합물을 여과한 여액에 2M 메탄올 메틸아민 용액(2.5㎖, 5mmol)을 가하고, 2시간 동안 교반시켰다. 용매를 감압 농축 시킨 후 목적화합물 1.68g(수율 96%)을 얻었다.5-chloro-2-methoxy-4-aminobenzoyl acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to acetonitrile (30 mL) slowly. Diethyl chlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. The reaction mixture was added 2M methanol methylamine solution (2.5 mL, 5 mmol) to the filtrate, and stirred for 2 hours. The solvent was concentrated under reduced pressure to obtain 1.68 g (96% yield) of the title compound.

1H-NMR(CDCl3, ppm) : δ 1.21(6H, t), 2.77(3H, d), 3.84(3H, s), 3.93(4H, q), 4.69(1H, broad), 6.45(1H, s), 6.84(2H, m), 7.69(1H, s) 1 H-NMR (CDCl 3 , ppm): δ 1.21 (6H, t), 2.77 (3H, d), 3.84 (3H, s), 3.93 (4H, q), 4.69 (1H, broad), 6.45 (1H , s), 6.84 (2H, m), 7.69 (1H, s)

[실시예 11]Example 11

[시스-4-디에틸포스포아미노-5-클로로-N-[1-카베톡시-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조][Preparation of cis-4-diethylphosphoamino-5-chloro-N- [1-carbetoxy-3-methoxy-4-piperidinyl] -2-methoxybenzamide]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 일수소탄산칼륨(2g, 20mmol), 탄산칼륨(2.7g, 20mmol)을 가하고, 천천히 디에틸 클로로포스페이트(1.6㎖, 11mmol)를 가한 후 4시간 동안 교반시켰다. 이 반응액에 시스-4-아미노-N-카베톡시-3-메톡시피페리딘(1.0g, 5mmol)을 가하고, 1시간 동안 교반시킨 후 여과하여 용매를 감압 농축 시킨 후 에틸아세테이트(30㎖× 3)으로 추출하여, 무수 황산나트륨으로 수분을 제거한 후 여과하였다. 이 여액을 감압농축하고, 이때 얻어진 오일상의 물질을 진공 건조하여 목적화합물 2.5g(수율 96%)을 얻었다.To 5-chloro-2-methoxy-4-aminobenzoic acid (1 g, 5 mmol), potassium monohydrogen carbonate (2 g, 20 mmol) and potassium carbonate (2.7 g, 20 mmol) were added to dichloromethane (30 mL), and slowly Diethyl chlorophosphate (1.6 mL, 11 mmol) was added and stirred for 4 hours. Cis-4-amino-N-carbetoxy-3-methoxypiperidine (1.0 g, 5 mmol) was added to the reaction solution, stirred for 1 hour, filtered, the solvent was concentrated under reduced pressure, and ethyl acetate (30 mL × Extracted with 3), filtered with anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure, and the oily substance thus obtained was vacuum dried to obtain 2.5 g (yield 96%) of the title compound.

m.p. : 136 ∼ 144℃m.p. : 136-144 ℃

1H-NMR(CDCl3, ppm) : δ 1.22(3H, t), 1.34(6H, t), 1.72(2H, s), 2.81(2H, m), 3.41(4H, s), 3.83(3H, s), 4.16(8H, m), 4.61(2H, s), 6.29(1H, s), 8.09(1H, s), 8.17(1H, broad) 1 H-NMR (CDCl 3 , ppm): δ 1.22 (3H, t), 1.34 (6H, t), 1.72 (2H, s), 2.81 (2H, m), 3.41 (4H, s), 3.83 (3H , s), 4.16 (8H, m), 4.61 (2H, s), 6.29 (1H, s), 8.09 (1H, s), 8.17 (1H, broad)

13C-NMR(CDCl3, ppm) : δ 13.95, 14.44, 15.76, 26.70, 42.52, 43.79, 48.74, 55.68, 56.63, 60.11, 61.12, 65.06, 75.68, 97.58, 110.71, 111.09, 132.29, 147.57, 155.70, 157.51, 163.60 13 C-NMR (CDCl 3 , ppm): δ 13.95, 14.44, 15.76, 26.70, 42.52, 43.79, 48.74, 55.68, 56.63, 60.11, 61.12, 65.06, 75.68, 97.58, 110.71, 111.09, 132.29, 147.57, 155.70, 157.51, 163.60

[비교예][Comparative Example]

[시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드의 제조]Preparation of [cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-methoxy-4-piperidinyl] -2-methoxybenzamide ]

디클로로메탄(30㎖)에 5-클로로-2-메톡시-4-아미노벤조일산(1g, 5 mmol)과 트리에틸아민(0.7㎖, 6mmol)을 용해시키고, 에틸클로로포메이트(0.57㎖, 6mmol)을 10℃에서 적가 시킨 후 45분 동안 교반시켰다. 이 반응액에 시스-1-[3-(4-플루오로페녹시)프로필]-4-아미노-3-메톡시피페리딘(1.4g, 5mmol)을 가하고, 18시간 동안 환류 교반시켰다. 이 반응 혼합물을 HPLC로 분리하여 목적 화합물 0.58g(수율 25%)와 5-클로로-2-메톡시-4-아미노벤조일산 이량체 0.08g(수율 4.25%)을 얻었으며, 기타 미반응물과 부반응이 남아 있는 것을 알 수 있다. 이 실험결과로부터 목적화합물에 대한 이량체의 생성율을 구하였다.5-chloro-2-methoxy-4-aminobenzoyl acid (1 g, 5 mmol) and triethylamine (0.7 mL, 6 mmol) were dissolved in dichloromethane (30 mL), and ethylchloroformate (0.57 mL, 6 mmol) was dissolved. ) Was added dropwise at 10 ° C. and stirred for 45 minutes. Cis-1- [3- (4-fluorophenoxy) propyl] -4-amino-3-methoxypiperidine (1.4 g, 5 mmol) was added to the reaction solution, and the mixture was stirred under reflux for 18 hours. The reaction mixture was separated by HPLC to obtain 0.58 g (yield 25%) of the target compound and 0.08 g (yield 4.25%) of 5-chloro-2-methoxy-4-aminobenzoylic acid dimer. It can be seen that this remains. From this test result, the production rate of dimer for the target compound was obtained.

또한, 이 반응 혼합물을 물(30㎖× 3)로 세척해 준 후, 무수 황산나트륨으로 수분을 제거하고 용매를 감압 농축 시킨 후 실리카겔 칼럼 크로마토그래피로 정제한 후, 각 분획을 감압 농축시켜 목적화합물 그리고 이때 부반응으로 생성된 5-클로로-2-메톡시-4-아미노벤조일산 이량체를 분리하여 NMR 및 원소분석을 하였다. 목적화합물에 대한 이량체의 생성율(HPLC 분석) : 17 %The reaction mixture was washed with water (30 mL × 3), dried over anhydrous sodium sulfate, concentrated under reduced pressure, purified by silica gel column chromatography, and concentrated under reduced pressure for each compound. At this time, 5-chloro-2-methoxy-4-aminobenzoyl acid dimer produced by side reaction was separated and subjected to NMR and elemental analysis. Production rate of dimer for target compound (HPLC analysis): 17%

이량체에 대한1H-NMR(CDCl3, ppm) : δ 3.83(3H, s), 4.00(3H, s), 4.60(2H, broad), 6.58(1H, s), 7.81(1H, s), 7.87(1H, s), 8.51(1H, s), 10.59(1H, s) 1 H-NMR for dimers: CDCl 3 , ppm: δ 3.83 (3H, s), 4.00 (3H, s), 4.60 (2H, broad), 6.58 (1H, s), 7.81 (1H, s) , 7.87 (1H, s), 8.51 (1H, s), 10.59 (1H, s)

이량체(C16H14C12N2O5: 385.20)의 원소분석Elemental Analysis of Dimers (C 16 H 14 C 12 N 2 O 5 : 385.20)

이론값 : C 49.9%, H 3.7%, N 7.3%Theoretical Values: C 49.9%, H 3.7%, N 7.3%

실험값 : C 49.874%, H 3.706%, N 7.255%Experimental value: C 49.874%, H 3.706%, N 7.255%

상술한 바와 같이, 본 발명은 아민기와 카복실기가 한 분자내에 존재하는 4-아미노벤조일산 유도체를 아민 유도체와 반응시킬 때, 구조적 특성으로 인한 중합체 및 이량체의 부반응이 수반되는 기존의 선행 기술의 제조 방법을 극복하였다. 즉, 포스페이트 화합물을 사용하여 4-아미노벤조일산을 활성화시킴과 동시에 아민기에 보호기를 도입시킨 신규한 화합물을 중간체로 제조함으로써 부반응 없는 고수율의 아실화 반응을 가능하게 하였다. 반응에 소요되는 시간에 있어서도, 기존 선행기술이 18시간 이상의 장시간이 소요되는 데 반하여 본 발명은 총 반응시간을 5 ∼ 7시간으로 대폭 감소시키는 효과를 가진다.As described above, the present invention relates to the preparation of a conventional prior art involving side reactions of polymers and dimers due to structural properties when 4-aminobenzoyl acid derivatives in which an amine group and a carboxyl group are present in one molecule are reacted with an amine derivative. Overcome the method. In other words, by using the phosphate compound to activate 4-aminobenzoic acid and at the same time to prepare a new compound incorporating a protecting group into an amine group as an intermediate, a high yield of acylation reaction without side reactions was made possible. Even in the time required for the reaction, while the prior art takes a long time of 18 hours or more, the present invention has the effect of greatly reducing the total reaction time to 5 to 7 hours.

또한, N-보호기 도입과정 및 탈보호기 과정이 포함된 다단계의 제조공정을 거치지 않고, 일용기반응(one-pot reaction)을 통하여 아민기 보호 및 카복실기 활성화 공정을 동시에 진행시킴으로써, 의약품으로서 유용한 상기 화학식 1로 표시되는 4-아미노벤즈아미드 유도체 및 산업적으로 유용한 펩타이드류의 공업적인 대량 생산을 가능하게 하였다.In addition, the amine group protection and the carboxyl group activation process are simultaneously performed through a one-pot reaction without undergoing a multi-step manufacturing process including an N-protecting group introduction process and a deprotecting group process. Industrial mass production of 4-aminobenzamide derivatives represented by the formula (1) and industrially useful peptides was made possible.

Claims (8)

다음 화학식 2로 표시되는 4-아미노벤조일산 유도체를 염기 존재하에 디클로로메탄, 1,2-디클로로에탄, 클로로포름 또는 아세토니트릴 중에서 선택한 용매 중에서 다음 화학식 3으로 표시되는 포스페이트 화합물과 반응시켜 카복실기의 활성화 및 아민보호기를 동시에 가지는 다음 화학식 4로 표시되는 4-포스포아미노벤조일산 포스페이트 유도체를 제조하고; 화학식 4로 표시되는 4-포스포아미노벤조일산 포스페이트 유도체와 다음 화학식 5로 표시되는 아민 유도체를 반응시켜 다음 화학식 6으로 표시되는 4-포스포아미노벤즈아미드 유도체를 제조한 후, 반응용액에 산(acid)을 첨가한 다음 통상의 방법으로 분리 회수하는 것을 특징으로 하는 다음 화학식 1로 표시되는 4-아미노벤즈아미드 유도체의 제조방법.The 4-aminobenzoyl acid derivative represented by the following formula (2) is reacted with a phosphate compound represented by the following formula (3) in a solvent selected from dichloromethane, 1,2-dichloroethane, chloroform or acetonitrile in the presence of a base to activate the carboxyl group and Preparing a 4-phosphoaminobenzoyl acid phosphate derivative represented by the following formula (4) having an amine protecting group simultaneously; By reacting the 4-phosphoaminobenzoyl acid phosphate derivative represented by the formula (4) with the amine derivative represented by the following formula (5) to prepare a 4-phosphoaminobenzamide derivative represented by the following formula (6), and then added an acid ( acid) is added and then recovered separately by a conventional method for producing a 4-aminobenzamide derivative represented by the following formula (1). [화학식 2][Formula 2] [화학식 3][Formula 3] [화학식 4][Formula 4] [화학식 5][Formula 5] [화학식 6][Formula 6] [화학식 1][Formula 1] 상기 화학식에서 ; R1은 C1∼C3의 직쇄 또는 분쇄의 알콕시기를 나타내고; R2는 수소원자, 또는 C1∼C3의 직쇄 또는 분쇄의 알킬기를 나타내고; R3은 수소원자, 또는 -(CH2)n-Z을 나타내고; n은 0 또는 1이고, 이때 Z은 수소원자, 디(C1∼C3의 알킬)아미노기, 또는를 나타내고; m는 0 또는 1이고, Q는 C1∼C3의 직쇄 또는 분쇄의 알콕시기이고, E는 수소원자, C1∼C3의 직쇄 또는 분쇄의 알킬옥시카보닐기, p-플루오로페녹시프로필기, 또는 벤질기를 나타내고; R4는 수소원자, 또는 C1∼ C3의 직쇄 또는 분쇄의 알킬기를 나타내고 ; R5는 C1∼ C3의 직쇄 또는 분쇄의 알킬기이며; X는 수소원자, 할로겐원자 또는 니트로기를 나타내고; Y는 할로겐원자를 나타내고; L은 산소원자를 나타낸다.In the above formula; R 1 is an alkoxy group of a linear or branched C 1 ~C 3; R 2 represents a hydrogen atom or a C 1 to C 3 straight or pulverized alkyl group; R 3 represents a hydrogen atom or-(CH 2 ) n -Z; n is 0 or 1, wherein Z is a hydrogen atom, a di (C 1 -C 3 alkyl) amino group, or Represents; and m is 0 or 1, Q is an alkoxy group of a linear or branched C 1 ~C 3, E is a phenoxy hydrogen atom, a straight-chain or alkyloxy carbonyl group, p- fluoro-milling of the C 1 ~C 3 Profile Group or benzyl group; R 4 represents a hydrogen atom or a C 1 to C 3 straight or pulverized alkyl group; R 5 is a C 1 to C 3 linear or pulverized alkyl group; X represents a hydrogen atom, a halogen atom or a nitro group; Y represents a halogen atom; L represents an oxygen atom. 제1항에 있어서, 상기 화학식 4 또는 화학식 6으로 표시되는 중간체의 분리 회수과정 없이 곧바로 다음 반응을 수행하는 것을 특징으로 하는 4-아미노벤즈아미드 유도체의 제조방법.The method for preparing 4-aminobenzamide derivatives according to claim 1, wherein the following reaction is performed immediately without separating and recovering the intermediate represented by Formula 4 or Formula 6. 제1항에 있어서, 상기 화학식 1로 표시되는 화합물이 시스-4-아미노-5-클로로-N-[1-[3-(4-플루오로페녹시)프로필]-3-메톡시-4-피페리딘일]-2-메톡시벤즈아미드인 것을 특징으로 하는 4-아미노벤즈아미드 유도체의 제조방법.The compound of claim 1, wherein the compound represented by Formula 1 is cis-4-amino-5-chloro-N- [1- [3- (4-fluorophenoxy) propyl] -3-methoxy-4- Piperidinyl] -2-methoxybenzamide. A process for producing 4-aminobenzamide derivatives. 제1항에 있어서, 반응용매로 디클로로메탄 또는 아세토니트릴을 사용하는 상기 화학식 1로 표시되는 화합물의 제조방법.The method according to claim 1, wherein dichloromethane or acetonitrile is used as the reaction solvent. 제1항에 있어서, 활성화제로 디알킬 할로포스페이트를 사용하는 상기 화학식 1로 표시되는 화합물의 제조방법.The method of claim 1, wherein dialkyl halophosphate is used as an activator. 다음 화학식 1로 표시되는 4-아미노벤즈아미드 유도체 제조에 중간체로 유용한 것임을 특징으로 다음 화학식 4로 표시되는 4-포스포아미노벤조일산 포스페이트 유도체.The 4-phosphoaminobenzoyl acid phosphate derivative represented by the following formula (4), characterized in that it is useful as an intermediate for the preparation of the 4-aminobenzamide derivative represented by the following formula (1). [화학식 4][Formula 4] [화학식 1][Formula 1] 상기 화학식에서 : R1, R2, R3, R4, R5, L 및 X는 각각 상기 청구항 1에서 정의한 바와 같다.In the formula: R 1 , R 2 , R 3 , R 4 , R 5 , L and X are as defined in claim 1, respectively. 제6항에 있어서, 상기 화학식 4로 표시되는 화합물이 5-클로로-2-메톡시-4-포스포아미노벤조일산 포스페이트인 것.According to claim 6, wherein the compound represented by Formula 4 is 5-chloro-2-methoxy-4-phosphoaminobenzoyl acid phosphate. 다음 화학식 1로 표시되는 4-아미노벤즈아미드 유도체 제조에 중간체로 유용한 것임을 특징으로 하는 다음 화학식 6으로 표시되는 4-포스포아미노벤즈아미드 유도체.The 4-phosphoaminobenzamide derivative represented by the following formula (6), characterized in that it is useful as an intermediate for the preparation of the 4-aminobenzamide derivative represented by the following formula (1). [화학식 6][Formula 6] [화학식 1][Formula 1] 상기 화학식에서 : R1, R2, R3, R4, R5, L 및 X는 각각 상기청구항 1에서 정의한 바와 같다.In the formula: R 1 , R 2 , R 3 , R 4 , R 5 , L and X are as defined in claim 1, respectively.
KR1019980010020A 1998-03-23 1998-03-23 A process for preparing 4-aminobenzamide derivatives KR100250335B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980010020A KR100250335B1 (en) 1998-03-23 1998-03-23 A process for preparing 4-aminobenzamide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980010020A KR100250335B1 (en) 1998-03-23 1998-03-23 A process for preparing 4-aminobenzamide derivatives

Publications (2)

Publication Number Publication Date
KR19990075682A KR19990075682A (en) 1999-10-15
KR100250335B1 true KR100250335B1 (en) 2000-04-01

Family

ID=19535249

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980010020A KR100250335B1 (en) 1998-03-23 1998-03-23 A process for preparing 4-aminobenzamide derivatives

Country Status (1)

Country Link
KR (1) KR100250335B1 (en)

Also Published As

Publication number Publication date
KR19990075682A (en) 1999-10-15

Similar Documents

Publication Publication Date Title
WO2001038321A1 (en) Improved process for preparing nitrogen-substituted aminotetralins
KR100250335B1 (en) A process for preparing 4-aminobenzamide derivatives
JP3054163B2 (en) Phosphinic acid ester-containing N-acyl-2-amino acid amide, process for producing the same and N-acyl-2-amino acid nitrile as precursor
Jurczak et al. Synthesis of N, N′-dimethyl diazacoronands via double-quaternization reaction
US5637704A (en) Preparation of hydroxyoxaalkylmelamines
KR100708581B1 (en) A process for the synthesis of ritonavir
KR20010005943A (en) Process for preparing 0-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
RU2571417C2 (en) Method of producing n-substituted 2-amino-4-(hydroxymethylphosphenyl)-2-butenoic acid
KR101153713B1 (en) Preparation method of itopride and intermediate compound
JP3640319B2 (en) Method for producing benzamide derivative
JP5279449B2 (en) Process for producing 5- {4- [2- (5-ethyl-2-pyridyl) ethoxy] benzyl} -2,4-thiazolidinedione hydrochloride
JPH0395192A (en) Azo compound
JP4181233B2 (en) Method for producing pyrrolidine-2,4-dione derivative
JP2659587B2 (en) 4-aziridinyl pyrimidine derivatives and their production
JPS5838261A (en) Novel 1,3-disubstituted imidazole derivative and its preparation
EP0281393B1 (en) Method for producing indan derivatives
JP2023548681A (en) New synthesis of L-phenylalanine amide
JP2734646B2 (en) Novel synthetic method of 2,2-difluorocarboxylic acid derivatives
KR100445781B1 (en) Process for preparing (S)-1-acetyl-2-pyrrolidinecarboxamide
JP2797559B2 (en) Nitrone compound and method for producing the same
KR20030055304A (en) Process for the preparation of protected 1-(1-aminoalkyl)-oxiranes
JP2022529000A (en) Method for Producing Substituted 2- [2- (Phenyl) Ethylamino] Alkaneamide Derivative
EP1564201A1 (en) Process for production of an acetylenic compound
JP2003342234A (en) Method for synthesizing hydroquinone monoester compound
EP0976733A1 (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee